Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2013 | 10-2012 | 07-2012 | 04-2012 | 01-2012 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -214 | -26 | -13 | -42 | 55 |
| Other Working Capital | -262 | 14 | -60 | -94 | 7 |
| Other Operating Activity | 230 | -4 | -50 | 24 | -90 |
| Operating Cash Flow | $-247 | $-16 | $-124 | $-112 | $-28 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | 0 | -2 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | 0 | 0 | -200 | N/A |
| Common Stock Issued | N/A | 0 | 0 | 1,000 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -12 | 0 |
| Financing Cash Flow | $0 | $0 | $0 | $788 | $N/A |
| Beginning Cash Position | 583 | 599 | 722 | 46 | 76 |
| End Cash Position | 337 | 583 | 599 | 722 | 46 |
| Net Cash Flow | $-247 | $-16 | $-124 | $676 | $-30 |
| Free Cash Flow | |||||
| Operating Cash Flow | -247 | -16 | -124 | -112 | -28 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -2 |
| Free Cash Flow | -247 | -16 | -124 | -112 | -30 |